Buy Acabrunat Acalabrutinib

Acabrunat 100mg capsules contain acalabrutinib, a prescription medication used for certain blood cancers. This oral therapy is designed for targeted action in chronic lymphocytic leukemia and mantle cell lymphoma. Store at room temperature and keep out of reach of children.

Strength

100mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Natco Pharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Acalabrutinib is prescribed to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also used for mantle cell lymphoma in patients who have received at least one prior therapy. This medication works by blocking signals that help cancer cells grow. Always follow your healthcare provider's guidance when using acalabrutinib.

Side Effects

Acabrunat 100mg capsules are taken by mouth and may help manage symptoms related to blood cancers. Some users report improved energy levels and reduced swelling in lymph nodes. Individual responses vary, and effects depend on the condition being treated. Regular monitoring is recommended during therapy.

Precautions & Warnings

Keep Acabrunat capsules in a cool, dry place away from direct sunlight. Do not open, crush, or chew the capsules. If a dose is missed, contact your healthcare provider for guidance. Inform your doctor about all medications and supplements you are taking before starting acalabrutinib.

Avoid Interactions

Acalabrutinib may interact with certain medications, including strong CYP3A inhibitors or inducers. Avoid grapefruit products while taking this medication, as they can affect how acalabrutinib works. Alcohol use should be discussed with your healthcare provider. Always review your full medication list with your doctor.

References

Frequently Asked Questions

Acabrunat 100mg capsules contain acalabrutinib and are prescribed for chronic lymphocytic leukemia and mantle cell lymphoma in adults.

Store Acabrunat 100mg capsules at room temperature, away from moisture and direct light.

Grapefruit products may interact with acalabrutinib; discuss with your healthcare provider before consuming them.

If you miss a dose, contact your healthcare provider for guidance rather than taking an extra dose.

Acabrunat contains acalabrutinib, which is a targeted therapy, not a traditional chemotherapy medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.